The DOI matches its Crossref record; 51 of the 54 references it cites were found in a registry or an index; 16 of the 54 sources its claims cite were checked for support.
Multicenter Evaluation of BioFire FilmArray Meningitis/Encephalitis Panel for Detection of Bacteria, Viruses, and Yeast in Cerebrospinal Fluid Specimens
Open accessAbstract
Multicenter evaluation of 1,560 prospectively collected CSF specimens showing high agreement for multiple targets on the BioFire ME panel.
Overview
CoChat Summary
TL;DR
The FilmArray ME Panel rapidly detects 14 pathogens directly from CSF with high specificity and mostly high sensitivity in a multicenter evaluation of 1,560 prospectively collected specimens. Sensitivity/PPA was 100% for 9 of 14 analytes, with lower values for enterovirus (95.7%) and HHV-6 (85.7%), and no detections of *L. monocytogenes* or *N. meningitidis*.
Key findings
- Among 1,560 CSF specimens, FilmArray detected at least one pathogen in 136 (8.7%); the most prevalent targets were enterovirus (51/136, 37.5%), HHV-6 (22/136, 16.2%), *S. pneumoniae* (16/136, 11.8%), HSV-2 (12/136, 8.8%), and HPeV (12/136, 8.8%).
- Sensitivity/PPA was 100% for 9 of 14 analytes; enterovirus was 95.7% (44/46) and HHV-6 was 85.7% (18/21). *L. monocytogenes* and *N. meningitidis* were not detected by FilmArray or culture, so sensitivity could not be calculated.
- For *S. agalactiae*, there was one false-positive and one false-negative result, giving sensitivity 0% and specificity 99.9%. Specificity/NPA was ≥99.2% for all analytes, and overall agreement between FilmArray and comparator testing was 99.8% (21,791/21,840).
- The investigational-use-only EBV target had PPA 81.8% and NPA 98.5% and was excluded from the final commercial ME Panel.
Methods
- Multicenter prospective evaluation at 11 geographically distinct U.S. sites from February through September 2014; residual CSF specimens collected by lumbar puncture with ≥500 μl uncentrifuged CSF, enrolled within 7 days, and repeat specimens excluded. Of 1,643 acquired specimens, 83 were excluded, leaving 1,560 in the final analysis.
- FilmArray ME Panel testing used approximately 200 μl of CSF with automated nucleic acid extraction, reverse transcription, amplification, and analysis in approximately 1 h. Comparator methods were bacterial culture for bacterial analytes and PCR plus bidirectional sequencing for viral and yeast analytes; discrepant results were investigated, but reported performance used unresolved data only.
- Sensitivity/PPA was calculated as 100 × [TP/(TP + FN)] and specificity/NPA as 100 × [TN/(TN + FP)], with exact binomial two-sided 95% confidence intervals by the Wilson score method.
Limitations
- Stated: clinical data were analyzed retrospectively; full clinical data were not available for all patients; records for readmissions, follow-up treatment, or additional testing after LP were not accessible; standard CSF testing differed across sites and could affect discrepancy investigation; pretest probability for infectious ME was not controlled because enrollment was based on CSF culture submission with sufficient residual volume.
- Stated: there were 22 unresolved false-positive results, with possible contamination during aliquoting/testing or from oral flora/operator; the panel does not provide antibiotic susceptibility information and does not cover all bacterial CNS pathogens, so culture and Gram stain remain necessary.
- Evident from the text: low prevalence of many targets yielded few positive detections and wide or incalculable confidence intervals for several analytes, limiting precision of performance estimates.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
8 Valid · 5 Not valid · 24 Not checked · 141 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“This leads to delays, which can have significant clinical consequences if therapy is delayed or incorrectly administered (9–11).”
What the sources say
- Partly supportedcites [9] Shah SS, Aronson PL, Mohamad Z, Lorch SA. 2011. Delayed acyclovir therapy and death among neonates with herpes simplex virus infection. Pediatrics 128:1153–1160. doi: 10.1542/peds.2011-0177. [DOI] [PMC free article] [PubMed] [Google Scholar] sourceExperimental — accuracy not yet measured
The Outcome Measures passage reports that death rates rose with each additional day before acyclovir treatment began in neonates with HSV infection. The paper does not establish that delays in CSF testing caused treatment delays, and it does not examine incorrectly administered therapy as an outcome. No page numbers are available in our copy. (LLM, conf=0.83)
- Not checked — no full text of the sourcecites [10] Barquet N, Domingo P, Cayla JA, Gonzalez J, Rodrigo C, Fernandez-Viladrich P, Moraga-Llop FA, Marco F, Vazquez J, Saez-Nieto JA, Casal J, Canela J, Foz M. 1997. Prognostic factors in meningococcal disease. Development of a bedside predictive model and scoring system. Barcelona Meningococcal Disease Surveillance Group. JAMA 278:491–496. [DOI] [PubMed] [Google Scholar] source
- Partly supportedcites [11] Cartwright K, Reilly S, White D, Stuart J. 1992. Early treatment with parenteral penicillin in meningococcal disease. BMJ 305:143–147. doi: 10.1136/bmj.305.6846.143. [DOI] [PMC free article] [PubMed] [Google Scholar] sourceExperimental — accuracy not yet measured
The Introduction links diagnostic or therapeutic delay in meningococcal disease to higher mortality, and the section on antibiotics before admission warns that delaying treatment to confirm a diagnosis can be fatal. The paper does not establish that delays in CSF testing cause treatment delays, or that incorrectly administered therapy has the stated clinical consequences. The indexed passages provide section labels but no page numbers. (LLM, conf=0.86)
plainstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“It has been shown that cryptococcal antigen can remain positive for long periods of time after therapy, even when culture and smears are negative (40).”
What the sources say
- Supportedcites [40] Lu H, Zhou Y, Yin Y, Pan X, Weng X. 2005. Cryptococcal antigen test revisited: significance for cryptococcal meningitis therapy monitoring in a tertiary Chinese hospital. J Clin Microbiol 43:2989–2990. doi: 10.1128/JCM.43.6.2989-2990.2005. [DOI] [PMC free article] [PubMed] [Google Scholar] source
The paper reports that cryptococcal antigen remained detectable for months after successful therapy. Its results also state that antigen remained detectable when both fungal stain and culture had turned negative. (LLM, conf=0.94)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“The definitive diagnosis of bacterial meningitis has been historically based on isolation in culture, which has a sensitivity of, on average, approximately 80% or greater (1).”
What the sources say
- Could not verifycites [1] Brouwer MC, Tunkel AR, van de Beek D. 2010. Epidemiology, diagnosis, and antimicrobial treatment of acute bacterial meningitis. Clin Microbiol Rev 23:467–492. doi: 10.1128/CMR.00070-09. [DOI] [PMC free article] [PubMed] [Google Scholar] sourceExperimental — accuracy not yet measured
The table of contents lists a “CSF Cultures” section on p. 475, but its text is absent from our truncated copy. The Introduction reports that bacteria could not be cultured in 33% of cases in one Brazilian case series; that does not establish an average culture sensitivity or the historical basis of definitive diagnosis. Searches for CSF culture sensitivity and the approximately 80% figure did not find a passage that settles the claim. (LLM, conf=0.76)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The FilmArray ME Panel demonstrated a sensitivity or positive percentage of agreement of 100% for 9 of 14 analytes.”
boostedn = 1,560- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“All other assay targets were detected in 7 (5%) or fewer of the specimens.”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
55 more claims
Create a free account to see all 178 claims and to verify the 1 reference still open.
- Probably not a substantial claim. 64
- It may state two separate claims as one. 78
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“Overall accuracy between gold standard testing and the ME panel is reported between 93 and 99% (15–23).”
From Clinical Utilization of the FilmArray Meningitis/Encephalitis (ME) Multiplex Polymerase Chain Reaction (PCR) Assay (2019) · cites this paper as [17]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Causes of FP are related to sample contamination and cross-reactivity with other bacteria.8,10”
From Biofire FilmArray Meningitis/Encephalitis panel for the aetiological diagnosis of central nervous system infections: A systematic review and diagnostic test accuracy meta-analysis (2022) · cites this paper as [10]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Timely and accurate diagnosis of CNS infections is essential to avoid unnecessary antimicrobial therapy, reduce diagnostic uncertainty, limit hospital stay, and ultimately prevent morbidity and mortality.10,11”
From Utility and clinical relevance of multiplex PCR panels for diagnosis of central nervous system infections (2026) · cites this paper as [10]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Finally, CSF ME panel is not recommended to be performed in the CSF from shunt as it does not include Staphylococcus species, coagulase-negative staphylococci, Cutibacterium acnes, or Corynebacterium species, which are common causes of shunt infection [11].”
From Clinical utility of a cerebrospinal fluid multiplex PCR meningitis/encephalitis panel in children: a retrospective review of positive results (2026) · cites this paper as [11]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Previous studies have demonstrated the accuracy and clinical utility of FA-M/E in adults from North America and some European countries (5–8).”
From Epidemiology of pediatric meningitis and encephalitis in Japan: a cross-sectional study (2024) · cites this paper as [7]
Experimental — accuracy not yet measured
35 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
“The resulting performance characteristics were a PPA of 81.8% (95% CI, 61.5 to 92.7) with two false-negative results”
Reported 2 · recomputed 4
Citations
Cites
Kaper, J. B., Nataro, J. P., & Mobley, H. L. T. (2004) · Nature Reviews Microbiology · doi:10.1038/nrmicro818 · Cited by 5,583 · cited 13×
“They are critical pathogens in certain populations, including immunosuppressed patients (34), and are best detected in the CNS by molecular methods (23).”
BackgroundInfluentialTwo-sided confidence intervals for the single proportion: comparison of seven methods
Newcombe, R. G. (1998) · Statistics in Medicine · doi:10.1002/(sici)1097-0258(19980430)17:8<857::aid-sim777>3.0.co;2-e · Cited by 5,107
Clinical features and prognostic factors in adults with bacterial meningitis
van de Beek, D., de Gans, J., Spanjaard, L., Weisfelt, M., Reitsma, J. B., & Vermeulen, M. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040845 · Cited by 1,639
2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host
Rubin, L. G., Levin, M. J., Ljungman, P., Davies, E. G., Avery, R., Tomblyn, M., Bousvaros, A., Dhanireddy, S., Sung, L., Keyserling, H., et al. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/cit684 · Cited by 1,613
Acute Bacterial Meningitis in Adults -- A Review of 493 Episodes
Durand, M. L., Calderwood, S. B., Weber, D. J., Miller, S. I., Southwick, F. S., Caviness, V. S., & Swartz, M. N. (1993) · New England Journal of Medicine · doi:10.1056/nejm199301073280104 · Cited by 1,344
Bacterial Meningitis in the United States in 1995
Schuchat, A., Robinson, K., Wenger, J. D., Harrison, L. H., Farley, M., Reingold, A. L., Lefkowitz, L., & Perkins, B. A. (1997) · New England Journal of Medicine · doi:10.1056/nejm199710023371404 · Cited by 1,251
Bacterial Meningitis in the United States, 1998–2007
Thigpen, M. C., Whitney, C. G., Messonnier, N. E., Zell, E. R., Lynfield, R., Hadler, J. L., Harrison, L. H., Farley, M. M., Reingold, A., Bennett, N. M., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1005384 · Cited by 953
Epidemiology, Diagnosis, and Antimicrobial Treatment of Acute Bacterial Meningitis
Brouwer, M. C., Tunkel, A. R., & van de Beek, D. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00070-09 · Cited by 930 · cited 3×
“Gram stain has been assessed in cases of suspected meningitis and reported to have sensitivity ranging from 10 to 93%, depending on the organism and population being tested (1), and a near 100% specificity (21).”
BackgroundEdmond, K., Clark, A., Korczak, V. S., Sanderson, C., Griffiths, U. K., & Rudan, I. (2010) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(10)70048-7 · Cited by 631
Buss, S. N., Leber, A., Chapin, K., Fey, P. D., Bankowski, M. J., Jones, M. K., Rogatcheva, M., Kanack, K. J., & Bourzac, K. M. (2015) · Journal of Clinical Microbiology · doi:10.1128/jcm.02674-14 · Cited by 554 · cited 1×
“38%]) is consistent with other published data on different FilmArray panels and indicates there was not a significant amount of inhibition of PCR in the samples (15).”
ResultSelf-citation
Research works printed but not linked: 1
- BioFire Diagnostics. 2015. FilmArray Meningitis/Encephalitis (ME) Panel instruction booklet RF-Y-ASY-0118. BioFire Diagnostics, Salt Lake City, UT.
Cited by
Nervous system involvement after infection with COVID-19 and other coronaviruses
Wu, Y., Xu, X., Chen, Z., Duan, J., Hashimoto, K., Yang, L., Liu, C., & Yang, C. (2020) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2020.03.031 · Cited by 2,046
Chiu, C. Y., & Miller, S. A. (2019) · Nature Reviews Genetics · doi:10.1038/s41576-019-0113-7 · Cited by 1,620
Simner, P. J., Miller, S., & Carroll, K. C. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/cix881 · Cited by 821
“Gram stain), 10(2-3) CFU/ml for growth in culture, and 10-100 CFU/mL for nucleic acid amplification based methods [31].”
MethodSelf-citationMiller, J. M., Binnicker, M. J., Campbell, S., Carroll, K. C., Chapin, K. C., Gilligan, P. H., Gonzalez, M. D., Jerris, R. C., Kehl, S. C., Patel, R., et al. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy381 · Cited by 641
“Although an FDA-cleared multiplex PCR targeting 14 organisms is available for diagnosing meningitis and encephalitis, it should not be considered a replacement for culture since clinical experience with the assay is limited and specificity issues have been reported [17, 18].”
BackgroundSelf-citationMiller, J. M., Binnicker, M. J., Campbell, S., Carroll, K. C., Chapin, K. C., Gilligan, P. H., Gonzalez, M. D., Jerris, R. C., Kehl, S. C., Patel, R., et al. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy584 · Cited by 449
“Although an FDA-cleared multiplex PCR targeting 14 organisms is available for diagnosing meningitis and encephalitis, it should not be considered a replacement for culture since clinical experience with the assay is limited and specificity issues have been reported [17, 18].”
BackgroundSelf-citation
Metadata
- Authors
- Leber, A. L., Everhart, K., Balada-Llasat, J.-M., Cullison, J., Daly, J., Holt, S., Lephart, P., Salimnia, H., Schreckenberger, P. C., DesJarlais, S., Reed, S. L., Chapin, K. C., LeBlanc, L., Johnson, J. K., Soliven, N. L., Carroll, K. C., Miller, J.-A., Dien Bard, J., Mestas, J., Bankowski, M., Enomoto, T., Hemmert, A. C., & Bourzac, K. M.
- Affiliations
- Nationwide Children's Hospital (US)
- The Ohio State University Wexner Medical Center (US)
- Primary Children's Hospital (US)
- Detroit Medical Center (US)
- Loyola University Medical Center (US)
- University of California San Diego (US)
- Rhode Island Hospital (US)
- University of Maryland, Baltimore (US)
- Johns Hopkins University (US)
- Johns Hopkins Hospital (US)
- Children's Hospital Los Angeles, Los Angeles, California, USA
- Children's Hospital Los Angeles (US)
- University of Hawaiʻi at Mānoa (US)
- Diagnostic Laboratory Services (The Queen's Medical Center), Aiea, Hawaii, USA
- BioFire Diagnostics (United States) (US)
- ORCID
- Venue
- Journal of Clinical Microbiology
- Publisher
- American Society for Microbiology
- Published
- 2016-09
- Volume
- 54
- Issue
- 9
- Pages
- 2251-2261
- ISSN
- 0095-1137 (ISSN-L)
- 1098-660X
- PMC
- PMC5005480
- OpenAlex
- W2460625652
- Cited by
- 609
- References
- 54
- Citations by year
- 2026: 40 · 2025: 59 · 2024: 48 · 2023: 61 · 2022: 62 · 2021: 68 · 2020: 92 · 2019: 75 · 2018: 59 · 2017: 31 · 2016: 14
- FWCI
- 58.96
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Journal of Clinical Microbiology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Topics
- Health Sciences › Medicine › Microbiology (medical) › Bacterial Identification and Susceptibility Testing
- Life Sciences › Immunology and Microbiology › Microbiology › Bacterial Infections and Vaccines
- Health Sciences › Medicine › Infectious Diseases › Infectious Encephalopathies and Encephalitis
- Keywords
- FilmArray Meningitis/Encephalitis panel, infectious meningitis, encephalitis, cerebrospinal fluid, multiplex PCR, pathogen detection, sensitivity and specificity, Neisseria meningitidis, Streptococcus agalactiae, herpes simplex virus, cytomegalovirus, Cryptococcus neoformans, Listeria monocytogenes, Escherichia coli K1, Haemophilus influenzae, varicella-zoster virus, human herpesvirus 6, enterovirus, antimicrobial stewardship
- MeSH terms
- Adolescent, Adult, Aged, Aged, 80 and over, Bacteria, Bacterial Infections, Cerebrospinal Fluid, Child, Child, Preschool, Encephalitis, Female, Fungi, Humans, Infant, Infant, Newborn, Male, Meningitis, Middle Aged, Prospective Studies, Sensitivity and Specificity, Time Factors, Virus Diseases, Viruses, Central Nervous System Fungal Infections, Molecular Diagnostic Techniques, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-30, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-30 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Multicenter Evaluation of BioFire FilmArray Meningitis/Encephalitis Panel for Detection of Bacteria, Viruses, and Yeast in Cerebrospinal Fluid Specimens. https://app.cochat.ai/papers/10.1128/jcm.00730-16
- The paper
- Leber, A. L., Everhart, K., Balada-Llasat, J.-M., Cullison, J., Daly, J., Holt, S., Lephart, P., Salimnia, H., Schreckenberger, P. C., DesJarlais, S., Reed, S. L., Chapin, K. C., LeBlanc, L., Johnson, J. K., Soliven, N. L., Carroll, K. C., Miller, J.-A., Dien Bard, J., Mestas, J., . . . Bourzac, K. M. (2016). Multicenter Evaluation of BioFire FilmArray Meningitis/Encephalitis Panel for Detection of Bacteria, Viruses, and Yeast in Cerebrospinal Fluid Specimens. Journal of Clinical Microbiology. https://doi.org/10.1128/jcm.00730-16
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.